Clinical trials: Vinblastine

Breast Cancer

INVINCIBLE TRIAL: Intratumoral INT230-6 in Breast Cancer

• Unknown status
• Age: All ages
• Phase 2
• Injection or infusion

This is a phase II, randomized, multi-center, parallel design, window of opportunity trial evaluating intratumoral INT230-6 in up to 90 patients with early stage breast cancer.

Trial name

NCT04781725

Testing

INT230-6, Saline injection

Where

Canada

Volunteers

90 people, healthy volunteers welcome

Sponsor

Ottawa Hospital Research Institute